Natera (NasdaqGS:NTRA) is expanding its oncology footprint through a CytoDyn partnership focused on real-world ctDNA insights in metastatic colorectal cancer. The company also partnered with Diakonos ...

Purpose: To determine the prevalence of chromosomal abnormalities in fetuses with prenatally diagnosed pleural effusions and to identify factors associated with an increased risk of aneuploidy.

Experts say growing awareness about the difference between screening and diagnostic tests can help families make informed ...

A woman's first prenatal visit sets the stage for several firsts: first ultrasound, first blue or pink (or yellow) shopping trip, and months later, the first time she meets her baby. The first ...

BrightHeart, a global leader in AI-driven prenatal ultrasound, today announced the availability of its B-Right AI Platform through GE HealthCare’s Voluson™ Solution Store, bringing advanced AI support ...

A prenatal test taken by millions of pregnant women globally was developed by Chinese gene company BGI Group in collaboration ...

This release is also available in German. Results of a study from Australia in this week's issue of THE LANCET provide reassurance to the safety of repeated ultrasound examination during pregnancy. 10 ...

BrightHeart is a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, with an AI software platform that delivers support across the entire ultrasound exam, providing ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...